Cell-penetrating peptide-oligonucleotide conjugation combines a sequence-defined nucleic acid cargo with a cell-penetrating peptide (CPP) to create a discrete molecular construct for intracellular delivery research. CPPs can promote cellular internalization of oligonucleotides, but useful performance depends on much more than peptide uptake alone. Peptide charge and amphipathicity, oligonucleotide chemistry, conjugation position, linker architecture, solution behavior, intracellular trafficking, and endosomal release can all influence whether a CPP-oligonucleotide conjugate is suitable for the intended experiment.
Our cell-penetrating peptide-oligonucleotide conjugation services support research teams developing defined CPP conjugates with DNA, RNA, antisense oligonucleotides, siRNA, PMO, PNA, and related nucleic acid formats. Projects can include construct architecture planning, peptide and oligonucleotide functionalization, linker selection, site-specific coupling, purification strategy development, and analytical characterization. For broader projects, these capabilities can be coordinated with our oligonucleotide conjugation services and peptide-oligonucleotide conjugation workflows.
.jpg)
Figure 1. Glycosylated cell-penetrating peptides(GCPPs).( Gallego, I; et al, 2019)
Cell Entry Is Not Cytosolic Access: A conjugate may show substantial cellular association or endocytic uptake while only a fraction reaches the intracellular compartment required for oligonucleotide function. CPP selection should therefore consider trafficking and endosomal escape requirements rather than relying on uptake measurements alone.
Attachment Position Can Disrupt Function: Conjugating a bulky or highly charged peptide at the wrong oligonucleotide terminus, internal position, or siRNA strand can interfere with hybridization, duplex behavior, protein interactions, or downstream assay performance. We plan the conjugation topology around the functional requirements of the nucleic acid cargo.
Charge Drives Handling Problems: Many CPPs are rich in arginine or lysine, whereas conventional DNA and RNA are strongly anionic. Combining these components can produce charge-driven association, aggregation, broad chromatographic peaks, or difficult separation of free peptide, free oligonucleotide, and final conjugate. Chemistry and purification therefore need to be designed together.
Linker Choice Changes Conjugate Behavior: A permanent linker is appropriate when the peptide should remain attached, whereas a cleavable design may be useful when cargo release is part of the experimental hypothesis. Spacer length, hydrophilicity, steric demand, and bond stability can also influence solubility and accessibility of both components.
Reactive Handles Must Be Orthogonal: CPPs may contain multiple lysines, cysteines, acidic residues, or other reactive groups. Oligonucleotides may also contain functional modifications that constrain the available chemistry. Defined handle placement using thiol, maleimide, azide, alkyne, amino, or related groups helps reduce heterogeneous coupling. Our thiol modifiers and spacer modifier capabilities can support compatible construct designs.
Quality Requires Conjugate-Specific Analytics: Measuring oligonucleotide purity before conjugation does not establish the identity or composition of the final CPP conjugate. The finished material requires analytical methods capable of distinguishing desired product from unconjugated components, coupling-related variants, aggregates, and other project-relevant impurities.
CPP-oligonucleotide conjugates are chemically asymmetric molecules: the peptide and nucleic acid components differ substantially in charge, hydrophobicity, solubility, and analytical behavior. Our service strategy therefore begins with the intended cargo and experimental objective before selecting handles, linkers, coupling chemistry, purification conditions, and analytical endpoints.
Support can be configured for a single defined construct, comparative CPP or linker panels, or research programs that require several oligonucleotide modalities or conjugation architectures.
There is no single coupling chemistry that is optimal for every CPP-oligonucleotide construct. Selection should account for the available reactive handles, CPP sequence, oligonucleotide modifications, desired bond stability, allowable reaction conditions, steric effects, and downstream purification strategy.
| Conjugation Strategy | Typical Reactive Handles | Linkage Behavior | Why It May Be Selected | Design Considerations |
| Thiol-Maleimide | Peptide cysteine or thiol + oligonucleotide maleimide, or reciprocal arrangement | Predominantly non-cleavable thioether-type connection | Convenient site-directed coupling under relatively mild aqueous conditions | Maleimide stability, cysteine placement, competing thiols, peptide oxidation state, and final conjugate stability |
| Disulfide Chemistry | Thiol + activated disulfide or complementary thiol functionality | Reduction-sensitive connection | Useful when a releasable connection is part of the experimental design | Oxidation during preparation, reducing environments, premature cleavage, and storage conditions |
| CuAAC Click Chemistry | Azide + terminal alkyne | Stable triazole linkage | Highly orthogonal modular assembly with defined reactive handles | Copper compatibility, catalyst removal, reaction workup, and sensitivity of other molecular components |
| SPAAC Click Chemistry | Azide + strained cyclooctyne such as DBCO-type functionality | Stable triazole-containing connection | Copper-free coupling when metal exposure is undesirable | Handle size, hydrophobicity, steric demand, reagent stability, and possible effects on purification |
| Amide Coupling | Amine + activated carboxyl functionality | Stable amide bond | Chemically robust linkage using widely accessible functional groups | Selectivity can be difficult when a CPP contains multiple unprotected amines or other competing nucleophiles |
| Carbonyl-Based Coupling | Aldehyde or ketone + aminooxy or hydrazide functionality | Oxime- or hydrazone-type connection depending on the selected handles | Provides an additional chemoselective option for architectures incompatible with other coupling routes | Reaction pH, bond stability, handle installation, and the required long-term behavior of the conjugate |
The same CPP and linker cannot be assumed to behave identically across different nucleic acid cargos. Charge-neutral PMO and PNA, highly anionic DNA or RNA, phosphorothioate-containing ASOs, and duplex siRNA each create different constraints for conjugation topology, purification, solution behavior, and functional validation.
| Oligonucleotide Cargo | Conjugation Planning | Key Technical Risks | Analytical Focus | Typical Research Direction |
| DNA Oligonucleotide | Terminal attachment is often convenient; internal attachment can be considered when sequence function permits | Charge-driven association with cationic CPPs, altered hybridization, and purification overlap | Conjugate identity, purity, residual free components, and sequence integrity | Intracellular probes, delivery-model studies, and nucleic acid localization experiments |
| RNA Oligonucleotide | Select handles and coupling conditions compatible with the RNA modification pattern and required structural behavior | RNA stability, side reactions, secondary structure, and difficult charge-based purification | Identity, purity, intact RNA component, and conjugate integrity | RNA uptake, localization, and intracellular interaction studies |
| Antisense Oligonucleotide | Attachment site is selected to minimize interference with target recognition and the intended antisense mechanism | Modification-dependent chemistry, steric effects, CPP interactions, and altered solution behavior | Molecular identity, purity, conjugate composition, and application-relevant integrity | Research-stage antisense uptake, localization, and sequence-function studies |
| siRNA | Conjugation is planned with strand identity, terminal position, duplex formation, and RNAi-related structural requirements in mind | Impaired duplex behavior, strand-specific interference, aggregation, and incomplete separation of free CPP | Conjugate identity, strand composition, duplex quality, and purity | Peptide-siRNA delivery and intracellular gene-silencing research |
| PMO | CPP and linker architecture are selected around the charge-neutral morpholino backbone and intended steric-blocking experiment | Endosomal sequestration, peptide-dependent solubility, attachment-site effects, and purification complexity | Conjugate identity, purity, peptide-to-PMO composition, and intact construct confirmation | PPMO uptake, splice-modulation research, and intracellular trafficking studies |
| PNA | Peptide sequence, linker length, and attachment position are coordinated with PNA solubility and hybridization requirements | Aggregation, sequence-dependent solubility, endosomal retention, and steric effects on target recognition | Identity, purity, conjugate integrity, and application-specific handling behavior | Antisense PNA, intracellular probes, hybridization research, and delivery comparisons |
A reliable CPP-oligonucleotide project requires coordination between nucleic acid design, peptide chemistry, conjugation chemistry, purification, and analytical review. Our workflow establishes these dependencies before coupling begins so that the final construct is designed for both chemical feasibility and downstream research use.
We review the oligonucleotide sequence and modality, CPP sequence or desired peptide characteristics, existing modifications, requested amount, purity expectations, intended assay, and whether either component will be supplied by the customer. This establishes the functional constraints that the conjugation design must preserve.
Available attachment positions and functional groups are evaluated before selecting a permanent or cleavable linker and compatible coupling chemistry. Particular attention is given to peptide side-chain reactivity, oligonucleotide modifications, steric demand, expected solubility, and anticipated purification difficulty.
The peptide and oligonucleotide components are prepared with the agreed orthogonal reactive handles. Where appropriate, terminal spacers or functional groups are incorporated during synthesis so that coupling can proceed at a defined position rather than through uncontrolled multi-site modification.
Coupling conditions are selected according to the chosen reaction and the physicochemical behavior of both components. Reaction stoichiometry, solvent or buffer conditions, concentration, oxidation state, and workup are adjusted as needed to favor the intended conjugate and simplify downstream separation.
The crude reaction mixture is purified using a method matched to conjugate charge, hydrophobicity, molecular size, and impurity profile. The purified construct is then evaluated using the agreed analytical package to confirm identity and assess purity before material release.
Final material is supplied with project-relevant analytical information and construct details. For follow-on work, we can review observations such as unexpected solubility, uptake behavior, or assay interference and use them to guide CPP, linker, attachment-site, or control-construct iterations.
Figure 2. Service flow of CPP-oligonucleotide conjugation.
The most useful CPP conjugate is not necessarily the construct with the strongest peptide charge or the simplest coupling reaction. Successful research material must balance oligonucleotide function, CPP behavior, conjugation selectivity, purification feasibility, and analytical confidence. Our service approach keeps these variables connected throughout project planning and execution.
Cell-penetrating peptide conjugates are useful research tools when a defined covalent format is preferred for studying how peptide architecture affects oligonucleotide uptake, trafficking, localization, and function. Application design should remain cargo-specific because CPP performance can vary substantially with conjugate chemistry and experimental context.
Whether you are developing a CPP-ASO, peptide-siRNA conjugate, PPMO, CPP-PNA construct, intracellular probe, or comparative peptide-delivery panel, the most useful project plan begins with the complete molecular architecture rather than the coupling reaction alone. Share your oligonucleotide sequence or modality, CPP sequence or desired peptide characteristics, preferred attachment position, modifications, linker requirements, quantity, purity expectations, and intended research workflow. We can use these inputs to define a practical conjugation route, purification strategy, and analytical package for your construct. Contact us to discuss your cell-penetrating peptide-oligonucleotide conjugation requirements.
CPP-oligonucleotide conjugation involves linking cell-penetrating peptides (CPPs) with oligonucleotides to enhance the cellular uptake and intracellular delivery of oligonucleotides. This conjugation improves the bioavailability of the oligonucleotides and optimizes their therapeutic or imaging efficacy.
Cell-penetrating peptides (CPPs) are short peptides that can cross cell membranes efficiently. When conjugated with oligonucleotides, CPPs promote their entry into cells, enhancing their stability and effectiveness in intracellular environments, which is particularly useful for gene therapy and drug delivery.
CPPs are conjugated to oligonucleotides through covalent coupling, disulfide bond formation, or non-covalent complexation, depending on the application and desired outcome.
CPP-oligonucleotide conjugates are used in gene therapy, antimicrobial therapy, targeted delivery, and diagnostics by improving the efficiency and specificity of oligonucleotide delivery.
Loading ......
